The Evaluation of Free Gingival Graft Operations Around Implant or Teeth on Quality of Life
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04813081 |
|
Recruitment Status :
Completed
First Posted : March 24, 2021
Last Update Posted : March 24, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Patient Reported Outcome | Procedure: Free Gingival Graft | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 32 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The participants were defined as two study groups: Test Group (TG) consists of patients have free gingival graft around dental implant patients and Control Group (CG) consists of patients have free gingival graft around the teeth. |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | The Evaluation of Free Gingival Graft Operations Around Implant or Teeth on Quality of Life: Parallel-controlled Prospective Clinical Trial |
| Actual Study Start Date : | May 1, 2017 |
| Actual Primary Completion Date : | January 31, 2019 |
| Actual Study Completion Date : | March 4, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Free gingival graft around dental implant patients
Test Group (TG) consists of patients have free gingival graft around dental implant patients
|
Procedure: Free Gingival Graft
In the recipient area, a half-thickness flap with two vertical incision widths was removed with a horizontal incision with 15C blades from the mucogingival junction. The recipient site was determined such that one or two teeth or one tooth extends into the mesial and distal regions of the tooth. Muscle attachments were dissected and FGG was placed on recipient bed and non-resorbable monofilament sutures were used for fixing the four corners of the graft. |
|
Active Comparator: Free gingival graft around the teeth
Control Group (CG) consists of patients have free gingival graft around the teeth.
|
Procedure: Free Gingival Graft
In the recipient area, a half-thickness flap with two vertical incision widths was removed with a horizontal incision with 15C blades from the mucogingival junction. The recipient site was determined such that one or two teeth or one tooth extends into the mesial and distal regions of the tooth. Muscle attachments were dissected and FGG was placed on recipient bed and non-resorbable monofilament sutures were used for fixing the four corners of the graft. |
- General Oral Health Assesment Index (GOHAI) scores- intragroup comparisons change between from baseline to other follow-up times and intergroup comparisons all follow-up times [ Time Frame: Baseline, postoperative 1., 2., 3., 4., 5., 6. and 7. days and first month. ]The questions that contains 12 items and that give subcategorized about functional limitations, pain and discomfort, psychological impacts, and behavioral impact.
- Age [ Time Frame: baseline ]18-65 years
- Gender [ Time Frame: baseline ]male, female
- Keratinized gingival width (KGW) [ Time Frame: baseline, first month ]the distance between the gingival margin and mucogingival junction from tooth/implant in operation area
- Graft volume (GV) [ Time Frame: during surgery ]graft vertical height X graft mesiodistal length X graft thickness
- Surgery localization [ Time Frame: baseline ]maxilla, mandible, anterior, posterior
- Operation time [ Time Frame: during surgery ]operation time between of first incision and last suture
- Satisfaction questionnaires [ Time Frame: first month ]A questionnaire designed by authors with 12 questions was used to assess patient satisfaction. Answers were either categorized as "positive" or "negative".
- Visual Analog Scale (VAS) [ Time Frame: postoperative 1., 2., 3., 4., 5., 6. and 7. days ]a 100-mm horizontal scale and classify the level of postoperative pain experience from 0 (no pain) to 100 (the worst pain ever experienced)
- Painkiller consumption [ Time Frame: postoperative 1., 2., 3., 4., 5., 6. and 7. days ]the total number of painkillers for each follow-up day
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Non-smoking
- Teeth and implants with keratinized gingiva width <1 mm
- A healthy periodontal and peri-implant condition
- Patients who didn't have ever experience periodontal surgery had first oral surgery experience with dental FGG operation for the first time
- Patients who underwent implant surgery for the first oral surgery experience
- Maximum two teeth/implants on recipient area
Exclusion Criteria:
- Patients receiving any medication to disrupt wound healing
- Lactation or pregnancy
- Caries or defects on the tooth root surface
- Periapical lesion in the recipient area active periodontal disease
- Patients who have previously had periodontal or oral surgery experiences
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04813081
| Turkey | |
| Beykent University Faculty of Dentistry | |
| Istanbul, Turkey, 34500 | |
| Study Director: | serap karakış akcan, phd | Beykent University | |
| Principal Investigator: | berceste güler, phd | Kutahya Health Sciences University |
| Responsible Party: | Serap Karakış Akcan, Assistant professor doctor, University of Beykent |
| ClinicalTrials.gov Identifier: | NCT04813081 |
| Other Study ID Numbers: |
B.30.2.AYD.0.00.00-480.2/184 |
| First Posted: | March 24, 2021 Key Record Dates |
| Last Update Posted: | March 24, 2021 |
| Last Verified: | March 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
quality of life graft |

